Zelira Therapeutics (ASX:ZLD) Common Stock: A$45.52 Mil (As of Jun. 2025)


What is Zelira Therapeutics Common Stock?

Zelira Therapeutics ASX:ZLD Common Stock is A$45.52 Mil as of Jun. 2025. The stock has 7 warning signs investors should review.

Zelira Therapeutics's quarterly common stock stayed the same from Jun. 2024 (A$45.52 Mil) to Dec. 2024 (A$45.52 Mil) but then increased from Dec. 2024 (A$45.52 Mil) to Jun. 2025 (A$45.52 Mil).

Zelira Therapeutics's annual common stock stayed the same from Jun. 2023 (A$45.52 Mil) to Jun. 2024 (A$45.52 Mil) but then increased from Jun. 2024 (A$45.52 Mil) to Jun. 2025 (A$45.52 Mil).

Zelira Therapeutics Common Stock Historical Data

* Premium members only.

The historical data trend for Zelira Therapeutics's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zelira Therapeutics Common Stock Chart

Zelira Therapeutics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.65 43.75 45.52 45.52 45.52

Zelira Therapeutics Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.52 45.52 45.52 45.52 45.52

Zelira Therapeutics Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of A$45.52 Mil mean?
Zelira Therapeutics (ASX:ZLD) has a Common Stock of A$45.52 Mil as of Jun. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Zelira Therapeutics and its competitors.
Is Zelira Therapeutics' Common Stock too high?
Zelira Therapeutics' current Common Stock is A$45.52 Mil.
How does Zelira Therapeutics' Common Stock compare to MTNB and SXTP?
Zelira Therapeutics' Common Stock of A$45.52 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Zelira Therapeutics and its competitors. Zelira Therapeutics's current Common Stock is A$45.52 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zelira Therapeutics stock overvalued right now?
Zelira Therapeutics (ASX:ZLD) has a current Common Stock of A$45.52 Mil. The stock's GF Value™ is A$0.12, compared to a current price of A$0.50 — trading 316.7% above its estimated fair value. The current Common Stock is A$45.52 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Zelira Therapeutics (ASX:ZLD), the current Common Stock is A$45.52 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zelira Therapeutics Business Description

Other Exchanges ZLDAF:USA
Address 101 St George’s Terrace, Level 3, Perth, WA, AUS, 6000
Zelira Therapeutics Ltd is a biotechnology company focused on developing a range of cannabinoid-based formulations for the treatment of various medical conditions in Australia. The company is involved in a human clinical trial program focused on insomnia, autism, and eczema, and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer. The company is organised into two operating segments based on geographic location of operations: Australia and United States of America.